Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

SNDL vs ACB

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SNDL
SNDL Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$376M
5Y Perf.-83.0%
ACB
Aurora Cannabis Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$195M
5Y Perf.-97.6%

SNDL vs ACB — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SNDL logoSNDL
ACB logoACB
IndustryDrug Manufacturers - Specialty & GenericDrug Manufacturers - Specialty & Generic
Market Cap$376M$195M
Revenue (TTM)$937M$361M
Net Income (TTM)$-11M$41M
Gross Margin27.2%62.7%
Operating Margin-0.8%13.3%
Forward P/E164.2x
Total Debt$170M$104M
Cash & Equiv.$273M$184M

SNDL vs ACBLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SNDL
ACB
StockMay 20May 26Return
SNDL Inc. (SNDL)10017.0-83.0%
Aurora Cannabis Inc. (ACB)1002.4-97.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: SNDL vs ACB

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ACB leads in 3 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. SNDL Inc. is the stronger pick specifically for capital preservation and lower volatility and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
SNDL
SNDL Inc.
The Income Pick

SNDL is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • beta 1.18
  • Lower volatility, beta 1.18, Low D/E 15.4%, current ratio 4.88x
  • Beta 1.18, current ratio 4.88x
Best for: income & stability and sleep-well-at-night
ACB
Aurora Cannabis Inc.
The Growth Play

ACB carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 27.0%, EPS growth 102.2%, 3Y rev CAGR 15.8%
  • -92.0% 10Y total return vs SNDL's -98.3%
  • 27.0% revenue growth vs SNDL's 2.8%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthACB logoACB27.0% revenue growth vs SNDL's 2.8%
Quality / MarginsACB logoACB11.2% margin vs SNDL's -1.2%
Stability / SafetySNDL logoSNDLBeta 1.18 vs ACB's 1.81, lower leverage
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)SNDL logoSNDL+11.5% vs ACB's -25.3%
Efficiency (ROA)ACB logoACB5.2% ROA vs SNDL's -0.8%, ROIC 0.7% vs -0.3%

SNDL vs ACB — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SNDLSNDL Inc.
FY 2022
Cannabis
100.0%$62M
ACBAurora Cannabis Inc.

Segment breakdown not available.

SNDL vs ACB — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLACBLAGGINGSNDL

Income & Cash Flow (Last 12 Months)

ACB leads this category, winning 4 of 6 comparable metrics.

SNDL is the larger business by revenue, generating $937M annually — 2.6x ACB's $361M. ACB is the more profitable business, keeping 11.2% of every revenue dollar as net income compared to SNDL's -1.2%. On growth, ACB holds the edge at +6.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSNDL logoSNDLSNDL Inc.ACB logoACBAurora Cannabis I…
RevenueTrailing 12 months$937M$361M
EBITDAEarnings before interest/tax$49M$71M
Net IncomeAfter-tax profit-$11M$41M
Free Cash FlowCash after capex$53M-$31M
Gross MarginGross profit ÷ Revenue+27.2%+62.7%
Operating MarginEBIT ÷ Revenue-0.8%+13.3%
Net MarginNet income ÷ Revenue-1.2%+11.2%
FCF MarginFCF ÷ Revenue+5.6%-8.7%
Rev. Growth (YoY)Latest quarter vs prior year-4.4%+6.8%
EPS Growth (YoY)Latest quarter vs prior year+32.8%-94.5%
ACB leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

Evenly matched — SNDL and ACB each lead in 2 of 4 comparable metrics.

On an enterprise value basis, ACB's 6.7x EV/EBITDA is more attractive than SNDL's 7.9x.

MetricSNDL logoSNDLSNDL Inc.ACB logoACBAurora Cannabis I…
Market CapShares × price$376M$195M
Enterprise ValueMkt cap + debt − cash$301M$136M
Trailing P/EPrice ÷ TTM EPS-32.97x164.21x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple7.91x6.73x
Price / SalesMarket cap ÷ Revenue0.54x0.77x
Price / BookPrice ÷ Book value/share0.46x0.43x
Price / FCFMarket cap ÷ FCF8.83x
Evenly matched — SNDL and ACB each lead in 2 of 4 comparable metrics.

Profitability & Efficiency

ACB leads this category, winning 7 of 9 comparable metrics.

ACB delivers a 7.2% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-1 for SNDL. SNDL carries lower financial leverage with a 0.15x debt-to-equity ratio, signaling a more conservative balance sheet compared to ACB's 0.17x. On the Piotroski fundamental quality scale (0–9), ACB scores 7/9 vs SNDL's 6/9, reflecting strong financial health.

MetricSNDL logoSNDLSNDL Inc.ACB logoACBAurora Cannabis I…
ROE (TTM)Return on equity-1.0%+7.2%
ROA (TTM)Return on assets-0.8%+5.2%
ROICReturn on invested capital-0.3%+0.7%
ROCEReturn on capital employed-0.4%+0.7%
Piotroski ScoreFundamental quality 0–967
Debt / EquityFinancial leverage0.15x0.17x
Net DebtTotal debt minus cash-$102M-$80M
Cash & Equiv.Liquid assets$273M$184M
Total DebtShort + long-term debt$170M$104M
Interest CoverageEBIT ÷ Interest expense-1.16x6.27x
ACB leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

SNDL leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in SNDL five years ago would be worth $1,893 today (with dividends reinvested), compared to $385 for ACB. Over the past 12 months, SNDL leads with a +11.5% total return vs ACB's -25.3%. The 3-year compound annual growth rate (CAGR) favors SNDL at -5.7% vs ACB's -19.2% — a key indicator of consistent wealth creation.

MetricSNDL logoSNDLSNDL Inc.ACB logoACBAurora Cannabis I…
YTD ReturnYear-to-date-16.7%-21.0%
1-Year ReturnPast 12 months+11.5%-25.3%
3-Year ReturnCumulative with dividends-16.2%-47.2%
5-Year ReturnCumulative with dividends-81.1%-96.1%
10-Year ReturnCumulative with dividends-98.3%-92.0%
CAGR (3Y)Annualised 3-year return-5.7%-19.2%
SNDL leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — SNDL and ACB each lead in 1 of 2 comparable metrics.

SNDL is the less volatile stock with a 1.18 beta — it tends to amplify market swings less than ACB's 1.81 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.

MetricSNDL logoSNDLSNDL Inc.ACB logoACBAurora Cannabis I…
Beta (5Y)Sensitivity to S&P 5001.18x1.81x
52-Week HighHighest price in past year$2.89$6.67
52-Week LowLowest price in past year$1.15$3.07
% of 52W HighCurrent price vs 52-week peak+50.2%+51.4%
RSI (14)Momentum oscillator 0–10049.752.2
Avg Volume (50D)Average daily shares traded1.9M979K
Evenly matched — SNDL and ACB each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates SNDL as "Hold" and ACB as "Hold". Consensus price targets imply 172.4% upside for SNDL (target: $4) vs 72.6% for ACB (target: $6).

MetricSNDL logoSNDLSNDL Inc.ACB logoACBAurora Cannabis I…
Analyst RatingConsensus buy/hold/sellHoldHold
Price TargetConsensus 12-month target$3.95$5.92
# AnalystsCovering analysts614
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+3.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

ACB leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SNDL leads in 1 (Total Returns). 2 tied.

Best OverallAurora Cannabis Inc. (ACB)Leads 2 of 6 categories
Loading custom metrics...

SNDL vs ACB: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is SNDL or ACB a better buy right now?

For growth investors, Aurora Cannabis Inc.

(ACB) is the stronger pick with 27. 0% revenue growth year-over-year, versus 2. 8% for SNDL Inc. (SNDL). Aurora Cannabis Inc. (ACB) offers the better valuation at 164. 2x trailing P/E, making it the more compelling value choice. Analysts rate SNDL Inc. (SNDL) a "Hold" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — SNDL or ACB?

Over the past 5 years, SNDL Inc.

(SNDL) delivered a total return of -81. 1%, compared to -96. 1% for Aurora Cannabis Inc. (ACB). Over 10 years, the gap is even starker: ACB returned -92. 0% versus SNDL's -98. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — SNDL or ACB?

By beta (market sensitivity over 5 years), SNDL Inc.

(SNDL) is the lower-risk stock at 1. 18β versus Aurora Cannabis Inc. 's 1. 81β — meaning ACB is approximately 53% more volatile than SNDL relative to the S&P 500. On balance sheet safety, SNDL Inc. (SNDL) carries a lower debt/equity ratio of 15% versus 17% for Aurora Cannabis Inc. — giving it more financial flexibility in a downturn.

04

Which is growing faster — SNDL or ACB?

By revenue growth (latest reported year), Aurora Cannabis Inc.

(ACB) is pulling ahead at 27. 0% versus 2. 8% for SNDL Inc. (SNDL). On earnings-per-share growth, the picture is similar: Aurora Cannabis Inc. grew EPS 102. 2% year-over-year, compared to 84. 1% for SNDL Inc.. Over a 3-year CAGR, ACB leads at 15. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — SNDL or ACB?

Aurora Cannabis Inc.

(ACB) is the more profitable company, earning 0. 5% net margin versus -1. 7% for SNDL Inc. — meaning it keeps 0. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ACB leads at 1. 4% versus -0. 5% for SNDL. At the gross margin level — before operating expenses — ACB leads at 54. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — SNDL or ACB?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is SNDL or ACB better for a retirement portfolio?

For long-horizon retirement investors, SNDL Inc.

(SNDL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 18)). Aurora Cannabis Inc. (ACB) carries a higher beta of 1. 81 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SNDL: -98. 3%, ACB: -92. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between SNDL and ACB?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: SNDL is a small-cap quality compounder stock; ACB is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

SNDL

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 16%
Run This Screen
Stocks Like

ACB

Steady Growth Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 6%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform SNDL and ACB on the metrics below

Revenue Growth>
%
(SNDL: -4.4% · ACB: 6.8%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.